Chemical and Biological Defense Program - Office of the Under ...

UNCLASSIFIED
Exhibit P-40, Budget Item Justification Sheet: PB 2014 Chemical and Biological Defense Program Date: April 2013
Appropriation / Budget Activity / Budget Sub Activity:
0300D: Procurement, Defense-Wide / BA 03: Chemical/Biological Defense / BSA 1:
CBDP
P-1 Line Item Nomenclature:
MA0800 - JOINT BIO DEFENSE PROGRAM (MEDICAL)
ID Code (A=Service Ready, B=Not Service Ready) : A Program Elements for Code B Items: Other Related Program Elements:
MDAP/MAIS Code(s):
Item Schedule Prior Years FY 2012 FY 2013 FY 2014 Base FY 2014 OCO FY 2014 Total
Item Nomenclature* Exhibits
JM6677 - ADVANCED
ANTICONVULSANT
SYSTEM (AAS)
JM8788 - NEXT
GENERATION
DIAGNOSTICS SYSTEM
(NGDS)
JX0005 - DOD BIOLOGICAL
VACCINE PROCUREMENT
JX0210 - CRITICAL
REAGENTS PROGRAM
(CRP)
JX0300 -
BIOSURVEILLANCE (BSV)
Total Gross/Weapon
System Cost
ID Unit Cost
CD ($ K )
Qty
(Each)
Total Cost
($ M )
Unit Cost
($ K )
LI MA0800 - JOINT BIO DEFENSE PROGRAM (MEDICAL) UNCLASSIFIED
Chemical and Biological Defense Program Page 2 of 17 P-1 Line #92
Qty
(Each)
Total Cost
($ M )
Unit Cost
($ K )
Qty
(Each)
P5, P5A, P21 - - 0.000 - - - - - 4.466 - - 8.951 - - - - - 8.951
P5, P5A, P21 - - 0.000 - - 2.380 - - 26.934 - - 3.311 - - - - - 3.311
P5 - - 610.091 - - 0.180 - - 0.185 - - 0.185 - - - - - 0.185
P5 - - 18.912 - - 0.998 - - 1.012 - - - - - - - - -
P5 - - 0.000 - - - - - - - - 1.000 - - - - - 1.000
Total Cost
($ M )
Unit Cost
($ K )
Qty
(Each)
Total Cost
($ M )
Unit Cost
($ K )
Qty
(Each)
Total Cost
($ M )
Unit Cost
($ K )
Qty
(Each)
Total Cost
($ M )
633.893 3.558 32.597 13.447 - 13.447
*Item Nomenclature represents Item Number, DODIC, and Item Name for the P40A and P5; Name for the P18 and P23; Modification Number and Modification Title for the P3A; Item Number and Item Name for the P10.
Note: Totals in this Exhibit P-40 set may not be exact or add due to rounding.
Justification:
Continues support of the current national military strategy, specifically, a worldwide force projection capability that requires BW detection in order to protect the Force against potential threats. Operational
forces, contingency, special operations/low intensity conflict, counter narcotics, and other high-risk missions, have the immediate need to survive and sustain operations in a biological agent threat environment.
Operating forces have a critical need for defense from worldwide proliferation of BW capabilities and medical treatment of BW related casualties. The Joint Biological Defense Program will provide a tiered
strategy for detection and warning comprised of complementary detection/identification systems to provide theater protection against a large area and point attacks. The other biological defense mission
requirement is to provide US Forces with enhanced survivability and force protection through the introduction of Food and Drug Administration (FDA) approved vaccines to protect against current and emerging
threats, which could be deployed against maneuver units, or stationary facilities in the theater of operations.
48